Alnylam Pharmaceuticals (ALNY) Capital Expenditures (2009 - 2026)
Alnylam Pharmaceuticals' Capital Expenditures was $34.68 million in Q2 2026, up 142.6% from $14.29 million a year earlier and up 58.8% from the prior quarter.
Powered by 
Analysis
Alnylam Pharmaceuticals (ALNY) Capital Expenditures (2009 - 2026) Analysis & Trends
On a trailing twelve-month basis, Alnylam Pharmaceuticals' Capital Expenditures was $91.95 million through Jun 30, 2026, up 151.6% year-over-year; for FY2025, it came in at $58.7 million, up 71.2% from FY2024.
- Capital Expenditures shows a five-year compound annual growth rate of -3.6% (FY2020 to FY2025).
- In earlier years, Capital Expenditures was $34.28 million in FY2024 (-44.9%), $62.21 million in FY2023 (-13.7%), $72.06 million in FY2022 (-5.6%) and $76.37 million in FY2021 (+8.5%).
- The Q2 2026 figure marks the highest quarterly Capital Expenditures since Q4 2019.
- Compared with a year earlier, Capital Expenditures has increased for five straight quarters, with growth averaging 70.4% over the last eight quarters.
- The best year-over-year quarter for Capital Expenditures over five years was Q3 2025 (growth of 189.6%); the worst was Q3 2024 (a decline of 75.5%).
- Per Business Quant data, ALNY's Capital Expenditures in the three quarters before Q2 2026 was $21.83 million (Q1 2026), $23.29 million (Q4 2025) and $12.14 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,136.97 Bn | 1,105.55 Bn | 19.71 Bn | 2.93 Bn |
| 2 | Johnson & Johnson | 619.72 Bn | 538.25 Bn | 17.26 Bn | 1.32 Bn |
| 3 | AbbVie | 503.40 Bn | 476.52 Bn | 12.70 Bn | 322.00 Mn |
| 4 | Merck | 370.15 Bn | 324.53 Bn | 12.21 Bn | 893.00 Mn |
| 5 | Novartis Ag | 298.64 Bn | 262.63 Bn | 11.24 Bn | 321.00 Mn |
| 6 | Astrazeneca | 261.07 Bn | 234.76 Bn | 12.86 Bn | 1.86 Bn |
| 7 | Amgen | 237.00 Bn | 192.40 Bn | 7.24 Bn | 513.00 Mn |
| 8 | Gilead Sciences | 191.24 Bn | 165.43 Bn | 6.22 Bn | 140.00 Mn |
| 9 | Pfizer | 170.31 Bn | 116.96 Bn | 10.94 Bn | 533.00 Mn |
| 10 | Alnylam Pharmaceuticals | 30.06 Bn | 18.11 Bn | 992.69 Mn | 34.68 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 34.68 Mn |
| Mar 31, 2026 | 21.83 Mn |
| Dec 31, 2025 | 23.29 Mn |
| Sep 30, 2025 | 12.14 Mn |
| Jun 30, 2025 | 14.29 Mn |
| Mar 31, 2025 | 8.97 Mn |
| Dec 31, 2024 | 9.09 Mn |
| Sep 30, 2024 | 4.19 Mn |
| Jun 30, 2024 | 8.02 Mn |
| Mar 31, 2024 | 12.97 Mn |
| Dec 31, 2023 | 15.31 Mn |
| Sep 30, 2023 | 17.09 Mn |
| Jun 30, 2023 | 15.92 Mn |
| Mar 31, 2023 | 13.89 Mn |
| Dec 31, 2022 | 21.64 Mn |
| Sep 30, 2022 | 16.51 Mn |
| Jun 30, 2022 | 16.06 Mn |
| Mar 31, 2022 | 17.86 Mn |
| Dec 31, 2021 | 21.89 Mn |
| Sep 30, 2021 | 26.06 Mn |
API Access
Alnylam Pharmaceuticals Capital Expenditures API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ALNY&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "capital-expenditures", "ticker": "ALNY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=capital-expenditures&ticker=ALNY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();